N.F. Gamaleya Center and Petrovax Pharm join forces to advance innovative medicines
The National Research Center for Epidemiology and Microbiology named after N.F. Gamaleya of the Ministry of Health of the Russian Federation and the biopharmaceutical company Petrovax Pharm have signed a strategic cooperation agreement. The partnership is aimed at developing and producing novel pharmaceuticals to combat cancer, orphan, and infectious diseases. The cooperation will focus on substance manufacturing technology transfer projects.
Russia launches program to help breast cancer patients get innovative drug pyrotinib
Leading experts recommend including new drug camrelizumab in Clinical Guidelines for esophageal cancer
RUSSCO includes Areima® in the most preferred first-line regimen of nasopharyngeal cancer therapy
Conference in Moscow: Discussion of Quality-of-Life Improvement in Patients with Hepatic Cancer
Breakthrough in Treatment of Nasopharyngeal and Esophageal Cancer: New Drug Available in Russia
American Society of Clinical Oncology ASCO releases the data on Polyoxidonium use in cancer therapy
